MedTrace Logo

Clonidine Versus Granisetron for Shivering Prevension

NCT06031090 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 186

Last updated 2023-09-11

No results posted yet for this study

Summary

Prevention of post spinal anesthesia shivering during cesarean section with its associated discomfort, distress, aggravation of pain, increased metabolic demands, and increased oxygen consumption

Conditions

  • Post Spinal Anesthesia Shivering

Interventions

DRUG

Clonidine Injection

intravenous Clonidine 0.5 µg/kg diluted in 10ml normal saline 20 minutes before spinal anesthesia

DRUG

Granisetron Injection

intravenous 1mg of granisetron diluted in 10ml normal saline 20 minutes before spinal anesthesia.

DRUG

Normal Saline 10 mL Injection

intravenous 10 ml normal saline 20 minutes before spinal anesthesia

Sponsors & Collaborators

  • Zagazig University

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-05
Primary Completion
2023-10-05
Completion
2023-10-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06031090 on ClinicalTrials.gov